Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Viacell to present at Life Sciences Growth Conference and Chiron reports on initiation of a Phase I clinical trial of CHIR-258.
- M2 PRESSWIRE-3 June 2005-US Financial Network: Viacell to present at Life Sciences Growth Conference and Chiron reports on initiation of a Phase I clinical trial of CHIR-258C1994-2005 M2 COMMUNICATIONS LTD RDATE:03062005 City of Industry, CA - Defense industry news provided by Financial...
- Research articles 2005-06-03
- ViaCell and Genzyme announce collaboration and Genentech upgraded to Outperform.
- M2 PRESSWIRE-15 March 2005-US Financial Network: ViaCell and Genzyme announce collaboration and Genentech upgraded to OutperformC1994-2005 M2 COMMUNICATIONS LTD RDATE:15032005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). ViaCell, Inc. (Nasdaq: VIAC) and Genzyme...
- Research articles 2005-03-15
- StemCells provides update on stem cell trials and Viacell IPO superstar.
- M2 PRESSWIRE-2 February 2005-FNWU: StemCells provides update on stem cell trials and Viacell IPO superstarC1994-2005 M2 COMMUNICATIONS LTD RDATE:02022005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). StemCells Inc.(NASDAQ: STEM) said Tuesday that...
- Research articles 2005-02-02
Additional Resources
- ViaCell, Inc. [VIAC] President & CEO to Ring The NASDAQ Stock Market Closing Bell
- What: Marc D. Beer, President and Chief Executive Officer of ViaCell, Inc. (NASDAQ: VIAC) will preside over the closing bell. Where: NASDAQ MarketSite -- 4 Times Square -- 43rd & Broadway -- Broadcast Studio When: Friday, January 21, 2005 at 4:00 p.m. EST Why:...
- Research articles 2005-01-21
- ViaCell to Present at BIO CEO & Investor Conference 2007
- CAMBRIDGE, Mass. -- ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the BIO CEO & Investor Conference 2007 on Monday, February 12, 2007 at 11:00 a.m. Eastern Time at...
- Research articles 2007-02-05
- Leerink Swann & Company Initiates Coverage of ViaCell, Inc. (NASDAQ: VIAC)
- This morning, Senior Biotechnology Analyst, William Tanner, Ph.D., initiated coverage of ViaCell, Inc. with an Outperform rating. His investment rating is based on his belief that ViaCell has developed a proprietary technology platform that should permit the expansion of stem cells beyond past scale-up limitations and that this technology...
- Research articles 2005-06-23
- ViaCell Announces ViaCyte Manufacturing Agreement with Invitrogen
- CAMBRIDGE, Mass. -- ViaCell, Inc. (Nasdaq: VIAC) today announced it has entered into an agreement with Invitrogen to manufacture its ViaCyteSM media. ViaCyte is ViaCell's investigational product offering for use during assisted reproductive technology. The media manufactured by Invitrogen will be used in ViaCell's pivotal clinical trial to evaluate the...
- Research articles 2007-02-12
- ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
- CAMBRIDGE, Mass. -- ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Tuesday, July 10, 2007 at 3:00 p.m. at the...
- Research articles 2007-07-02
- First FDA Clearance of Sterile Field Cord Blood Collection Bag; ViaCell and Pall Announce Collaborative Agreement
- EAST HILLS, N.Y. & CAMBRIDGE, Mass. -- ViaCell, Inc. (NASDAQ: VIAC) and Pall Corporation (NYSE: PLL) announced today the first U.S. Food and Drug Administration clearance of a cord blood collection bag suitable for use in a sterile field. Pall and ViaCell collaborated on the development and design of the...
- Research articles 2006-04-25
- ViaCell to Present at the Deutsche Bank Health Care Conference
- CAMBRIDGE, Mass. -- ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the Deutsche Bank 32nd Annual Health Care Conference on Wednesday, May 2, 2007 at 4:45 p.m. at the...
- Research articles 2007-04-25
- ViaCell to Present at the Cowen and Company Healthcare Conference
- CAMBRIDGE, Mass. -- ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the Cowen and Company 27th Annual Healthcare Conference on Thursday, March 15, 2007 at 8:45 a.m. at the...
- Research articles 2007-03-08
- ViaCell to Present at the 2007 UBS Global Life Sciences Conference
- CAMBRIDGE, Mass. -- ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its business activities and product pipeline at the 2007 UBS Global Life Sciences Conference on Monday, September 24, 2007 at 12:00 p.m. at the Grand...
- Research articles 2007-09-18
- ViaCell to Present at the C.E. Unterberg, Towbin Life Sciences Conference
- CAMBRIDGE, Mass. -- ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its product pipeline and business activities at the C.E. Unterberg, Towbin Life Sciences Conference on Monday, October 30, 2006 at 4:00 p.m. Eastern Time at...
- Research articles 2006-10-23
- ViaCell to Report Fourth Quarter and Full Year 2006 Financial Results on February 27, 2007
- CAMBRIDGE, Mass. -- ViaCell, Inc. (Nasdaq: VIAC) will announce its fourth quarter and full year 2006 financial results on Tuesday, February 27, 2007 before the opening of U.S. financial markets. In connection with this announcement, ViaCell will host a conference call and live audio webcast on February 27, 2007 at...
- Research articles 2007-02-05
- ViaCell Names John F. Thero Chief Financial Officer
- CAMBRIDGE, Mass. -- ViaCell, Inc. (Nasdaq: VIAC) today announced the appointment of John F. Thero as the Company's Senior Vice President, Finance and Chief Financial Officer. In this role, he will have broad responsibility for all financial and administrative matters of the Company and be actively involved in corporate development...
- Research articles 2007-07-02
- ViaCell Announces Presentations at the Cowen and Company and Credit Suisse Healthcare Conferences
- CAMBRIDGE, Mass. -- ViaCell, Inc. (NASDAQ: VIAC) today announced that Marc D. Beer, President and Chief Executive Officer of ViaCell, will present an update on its product pipeline and business activities at two upcoming healthcare conferences. Mr. Beer will present at the Cowen and Company 7th Annual Global Healthcare Conference...
- Research articles 2006-10-31
- Viacell to Report First Quarter 2007 Financial Results on May 1, 2007
- CAMBRIDGE, Mass. -- ViaCell, Inc. (Nasdaq: VIAC) will announce its first quarter 2007 financial results on Tuesday, May 1, 2007 before the opening of U.S. financial markets. In connection with this announcement, ViaCell will host a conference call and live audio webcast on May 1, 2007 at 10:00 a.m. Eastern...
- Research articles 2007-04-17
- PerkinElmer Commences Cash Tender Offer for ViaCell
- WALTHAM & CAMBRIDGE, Mass. -- On October 12, 2007, Victor Acquisition Corp., an indirect wholly owned subsidiary of PerkinElmer, Inc. (NYSE: PKI), commenced a tender offer to acquire all outstanding shares of common stock of ViaCell, Inc. (Nasdaq: VIAC), at a price of $7.25 per share, in cash, pursuant to...
- Research articles 2007-10-12
- ViaCell Expands Study Sites in ViaCyte Pivotal Trial
- CAMBRIDGE, Mass. -- ViaCell, Inc. (Nasdaq: VIAC) today announced it expects to expand the number of U.S. clinical sites participating in its ViaCyteSMpivotal trial from three to eight. ViaCyte is an investigational product intended to broaden reproductive options for women through the freezing and thawing of human oocytes eggs. The...
- Research articles 2007-08-22
- ViaCell to Report Third Quarter 2006 Financial Results on November 2, 2006
- CAMBRIDGE, Mass. -- ViaCell, Inc. (Nasdaq: VIAC) will announce its third quarter 2006 financial results on November 2, 2006 before the opening of U.S. financial markets. In connection with this announcement, ViaCell will host a conference call and live audio webcast on November 2, 2006 at 10:00 a.m. Eastern Time...
- Research articles 2006-10-19
- << Previous
- page 1 of 1
- Next >>
